Latest Articles

Why compromise for less: Should PCSK9 inhibitors be initial therapy?

Single-Pill Combinations in Dyslipidemia

This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).

Use of Lipid-Lowering Therapies Over 2 Years

What do us physicians and patients think about LLTs and goals of treatment?

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Importance of lipid registries in cardiovascular prevention

Evaluation of lipid management following ACS

Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines